Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemoglobin01:24

Hemoglobin

9.8K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
9.8K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

5.9K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Kinase-Glo luminescent kinase assay for in vitro determination of PKA activity].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2012
Same author

Functional characterization of an arrestin gene on insecticide resistance of Culex pipiens pallens.

Parasites & vectors·2012
Same author

MiR-23a inhibits myogenic differentiation through down regulation of fast myosin heavy chain isoforms.

Experimental cell research·2012
Same author

Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.

PloS one·2012
Same author

Role of IKK/NF-κB signaling in extinction of conditioned place aversion memory in rats.

PloS one·2012
Same author

Inhibition of poly(ADP-ribose) polymerase attenuates acute kidney injury in sodium taurocholate-induced acute pancreatitis in rats.

Pancreas·2012
Same journal

Engineering a synthetic niche for hADSC preconditioning with PRP, Lp-SN, and resveratrol nanoparticles.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

<i>In-vitro</i> mineralization of borosilicate glasses and accompanying evolution of porous architecture.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Characterization of genipin-crosslinked gelatin/PVA hydrogels and the chondroprotective influence of hydroxytyrosol: an In vitro study.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Antibacterial and antibiofilm evaluation of biogenic ternary CuO-AgO-MgO nanocomposite against clinical isolates of carbapenem-resistant <i>Klebsiella pneumoniae</i>.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Folate receptor-targeted PEGylated PLGA nanoparticles for the site-specific delivery of hesperidin in epithelial ovarian cancer.

Artificial cells, nanomedicine, and biotechnology·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
05:05

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Published on: November 4, 2011

21.9K

Processing of ferulic acid modified hemoglobin.

Song Guo1, Pei Wang1, Chen Chen1

  • 1a School of Environmental and Chemical Engineering , Tianjin Polytechnic University , Tianjin , China.

Artificial Cells, Nanomedicine, and Biotechnology
|February 4, 2016
PubMed
Summary
This summary is machine-generated.

Ferulic acid modified hemoglobin (BAEGF-Hb) reduces toxicity from hemoglobin-based oxygen carriers (HBOCs) by quenching reactive oxygen species (ROS). This modification preserves hemoglobin structure and oxygen-carrying function.

Keywords:
Blood substituteP50ferulic acidhemoglobinradical scavenger

More Related Videos

Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology
07:07

Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology

Published on: March 12, 2015

10.1K
Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
10:23

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells

Published on: December 13, 2016

10.5K

Related Experiment Videos

Last Updated: Mar 26, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
05:05

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Published on: November 4, 2011

21.9K
Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology
07:07

Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology

Published on: March 12, 2015

10.1K
Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
10:23

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells

Published on: December 13, 2016

10.5K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Biochemistry

Background:

  • Hemoglobin-based oxygen carriers (HBOCs) face limited application due to toxicity.
  • Toxicity is primarily caused by the generation of reactive oxygen species (ROS).
  • Ferulic acid (FA) is known for its antioxidant and vasorelaxant properties.

Purpose of the Study:

  • To develop a novel, less toxic HBOC.
  • To investigate the efficacy of ferulic acid modification in mitigating HBOC-induced oxidative stress.
  • To assess the impact of ferulic acid modification on hemoglobin's structure and oxygen-binding capacity.

Main Methods:

  • Hemoglobin (Hb) was chemically modified with ferulic acid (FA) to create BAEGF-Hb.
  • Isoelectric focusing electrophoresis was used to confirm Hb modification.
  • UV-vis wavelength scanning assessed structural integrity.
  • Oxygen affinity curves determined the effect on P50 (partial pressure of oxygen at 50% saturation).

Main Results:

  • Successful modification of hemoglobin with ferulic acid was confirmed.
  • The modification did not alter the fundamental structure of hemoglobin.
  • Oxygen-binding affinity (P50) remained unaffected post-modification.
  • The modification degree of Hb was determined to be 4.

Conclusions:

  • Ferulic acid modification is a viable strategy to reduce HBOC toxicity.
  • BAEGF-Hb demonstrates potential as a safer alternative to conventional HBOCs.
  • Further research is warranted to explore the in vivo efficacy and safety of BAEGF-Hb.